Chen M-H, Liu Y-L, Kuo H-W, Tsai S-J, Hsu J-W, Huang K-L, et al. Neurofilament light chain is a novel biomarker for major depression and related executive dysfunction. Int J Neuropsychopharmacol. 2022;25(2):99–105.

Article  PubMed  CAS  Google Scholar 

Ménard C, Hodes GE, Russo SJ. Pathogenesis of depression: insights from human and rodent studies. Neuroscience. 2016;321:138–62.

Article  PubMed  Google Scholar 

Koppara A, Wagner M, Lange C, Ernst A, Wiese B, König H-H, et al. Cognitive performance before and after the onset of subjective cognitive decline in old age. Alzheimer’s Dementia: Diagnosis Assess Disease Monit. 2015;1(2):194–205.

Google Scholar 

Yuan A, Nixon RA. Neurofilament proteins as biomarkers to monitor neurological diseases and the efficacy of therapies. Front NeuroSci. 2021;15:689938.

Article  PubMed  PubMed Central  Google Scholar 

Andersson E, Janelidze S, Lampinen B, Nilsson M, Leuzy A, Stomrud E, et al. Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer’s disease. Neurobiol Aging. 2020;95:143–53.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ashton NJ, Janelidze S, Al Khleifat A, Leuzy A, van der Ende EL, Karikari TK, et al. A multicentre validation study of the diagnostic value of plasma neurofilament light. Nat Commun. 2021;12(1):3400.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sjögren M, Blomberg M, Jonsson M, Wahlund LO, Edman Å, Lind K, et al. Neurofilament protein in cerebrospinal fluid: a marker of white matter changes. J Neurosci Res. 2001;66(3):510–6.

Article  PubMed  Google Scholar 

Coelho A, Fernandes HM, Magalhães R, Moreira PS, Marques P, Soares JM, et al. Signatures of white-matter microstructure degradation during aging and its association with cognitive status. Sci Rep. 2021;11(1):4517.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jakimovski D, Kuhle J, Ramanathan M, Barro C, Tomic D, Hagemeier J, et al. Serum neurofilament light chain levels associations with gray matter pathology: a 5-year longitudinal study. Ann Clin Transl Neurol. 2019;6(9):1757–70.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Khalil M, Pirpamer L, Hofer E, Voortman MM, Barro C, Leppert D, et al. Serum neurofilament light levels in normal aging and their association with morphologic brain changes. Nat Commun. 2020;11(1):812.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Aggio V, Fabbella L, Finardi A, Mazza EB, Colombo C, Falini A, et al. Neurofilaments light: possible biomarker of brain modifications in bipolar disorder. J Affect Disord. 2022;300:243–8.

Article  PubMed  Google Scholar 

Sacher J, Neumann J, Fünfstück T, Soliman A, Villringer A, Schroeter ML. Mapping the depressed brain: a meta-analysis of structural and functional alterations in major depressive disorder. J Affect Disord. 2012;140(2):142–8.

Article  PubMed  Google Scholar 

Steinacker P, Al Shweiki MR, Oeckl P, Graf H, Ludolph AC, Schönfeldt-Lecuona C, et al. Glial fibrillary acidic protein as blood biomarker for differential diagnosis and severity of major depressive disorder. J Psychiatr Res. 2021;144:54–8.

Article  PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906.

Article  PubMed  Google Scholar 

McPheeters ML, Kripalani S, Peterson NB, Idowu RT, Jerome RN, Potter SA, et al. Quality improvement interventions to address health disparities: closing the quality gap-revisiting the state of the science. Database of abstracts of reviews of effects (DARE). Quality-assessed Reviews [Internet]; 2012.

Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000.

Al Shweiki MR, Steinacker P, Oeckl P, Hengerer B, Danek A, Fassbender K, et al. Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia. J Psychiatr Res. 2019;113:137–40.

Article  PubMed  Google Scholar 

Bai Y-M, Liu Y-L, Kuo H-W, Tsai S-J, Hsu J-W, Huang K-L, et al. Procollagen type 1 N-terminal propeptide, neurofilament light chain, proinflammatory cytokines, and cognitive function in bipolar and major depressive disorders: an exploratory study of brain–bone axis and systemic inflammation. J Psychiatr Res. 2023;158:403–8.

Article  PubMed  Google Scholar 

Bavato F, Cathomas F, Klaus F, Gütter K, Barro C, Maceski A, et al. Altered neuroaxonal integrity in schizophrenia and major depressive disorder assessed with neurofilament light chain in serum. J Psychiatr Res. 2021;140:141–8.

Article  PubMed  Google Scholar 

Hviid CV, Benros ME, Krogh J, Nordentoft M, Christensen SH. Serum glial fibrillary acidic protein and neurofilament light chain in treatment-naïve patients with unipolar depression. J Affect Disord. 2023.

Sifonios L, Trinchero M, Cereseto M, Ferrero A, Cladouchos M, Macedo GF, et al. An enriched environment restores normal behavior while providing cytoskeletal restoration and synaptic changes in the hippocampus of rats exposed to an experimental model of depression. Neuroscience. 2009;164(3):929–40.

Article  PubMed  CAS  Google Scholar 

Abdelhak A, Foschi M, Abu-Rumeileh S, Yue JK, D’Anna L, Huss A, et al. Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Reviews Neurol. 2022;18(3):158–72.

Article  CAS  Google Scholar 

Brinker T, Stopa E, Morrison J, Klinge P. A new look at cerebrospinal fluid circulation. Fluids Barriers CNS. 2014;11(1):1–16.

Article  Google Scholar 

Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T, et al. Neurofilaments as biomarkers in neurological disorders. Nat Reviews Neurol. 2018;14(10):577–89.

Article  CAS  Google Scholar 

Rosengren LE, Karlsson JE, Karlsson JO, Persson LI, Wikkelsø C. Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J Neurochem. 1996;67(5):2013–8.

Article  PubMed  CAS  Google Scholar 

Rissin DM, Kan CW, Campbell TG, Howes SC, Fournier DR, Song L, et al. Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat Biotechnol. 2010;28(6):595–9.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Byrne LM, Rodrigues FB, Blennow K, Durr A, Leavitt BR, Roos RA, et al. Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington’s disease: a retrospective cohort analysis. Lancet Neurol. 2017;16(8):601–9.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mattsson N, Cullen NC, Andreasson U, Zetterberg H, Blennow K. Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease. JAMA Neurol. 2019;76(7):791–9.

Article  PubMed  PubMed Central  Google Scholar 

Fiske A, Wetherell JL, Gatz M. Depression in older adults. Ann Rev Clin Psychol. 2009;5:363–89.

Article  Google Scholar 

Gudmundsson P, Skoog I, Waern M, Blennow K, Zetterberg H, Rosengren L, et al. Is there a CSF biomarker profile related to depression in elderly women? Psychiatry Res. 2010;176(2–3):174–8.

Article  PubMed  CAS  Google Scholar 

Yilmaz A, Blennow K, Hagberg L, Nilsson S, Price RW, Schouten J, et al. Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls. Expert Rev Mol Diagn. 2017;17(8):761–70.

Article  PubMed  CAS  Google Scholar 

Bridel C, Van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE, Alvarez-Cermeño JC, et al. Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis. JAMA Neurol. 2019;76(9):1035–48.

Article  PubMed  PubMed Central  Google Scholar 

Reinés A, Cereseto M, Ferrero A, Sifonios L, Podestá MF, Wikinski S. Maintenance treatment with fluoxetine is necessary to sustain normal levels of synaptic markers in an experimental model of depression: correlation with behavioral response. Neuropsychopharmacology. 2008;33(8):1896–908.

Article  PubMed  Google Scholar